Timothée Bruel

@timotheebruel.bsky.social

Group Leader / Antiviral Activities of Antibodies @Virus_Immunity @institutpasteur - Virology/Immunology - Member @SFV_France

Institut Pasteur 93 participants found complement made existing antibodies much better at neutralizing newer SARS-CoV-2 variants. It boosted conserved S2 antibodies by coating the virus with C3 instead of bursting it. www.science.org/doi/10.1126/...

Complement augments antibody neutralization of SARS-CoV-2 variants

Complement C1q and C3 potentiate neutralization activity of anti-S2 antibodies against SARS-CoV-2 variants via the Fc region.

science.org

🔬 New paper in Science Translational Medicine! @science.org The complement system boosts antibody neutralization of SARS-CoV-2, especially vs immune-evasive variants. Anti-S2 antibodies + complement = better survival in severe COVID-19. 🦠🛡️ www.science.org/doi/full/10.... @martin-jg.bsky.social

Complement augments antibody neutralization of SARS-CoV-2 variants

Complement C1q and C3 potentiate neutralization activity of anti-S2 antibodies against SARS-CoV-2 variants via the Fc region.

science.org

🔬 New paper in Science Translational Medicine! @science.org The complement system boosts antibody neutralization of SARS-CoV-2, especially vs immune-evasive variants. Anti-S2 antibodies + complement = better survival in severe COVID-19. 🦠🛡️ www.science.org/doi/full/10.... @martin-jg.bsky.social

Complement augments antibody neutralization of SARS-CoV-2 variants

Complement C1q and C3 potentiate neutralization activity of anti-S2 antibodies against SARS-CoV-2 variants via the Fc region.

science.org

The Bundibugyo virus outbreak in the DRC and Uganda has focused concern on potential countermeasures. Investigators assessed cross-reactive immune responses in serum obtained during previous Ebola vaccine trials. Learn more: https://nej.md/4b67kVe

This image is a series of box plots showing binding antibody response at 28 days and 3 months after rVSV, rVSV Booster, and Ad26.MVA Vaccination. In Panel A, pooled rVSV Groups (N=38) and Ad26.MVA (N=17) are displayed. Panel B shows rVSV (one dose) (N=44), rVSV booster (N=25), and Ad26.MVA groups (N=55). Plots are color-coded and categorize data for different age groups, labeled as Adult and Child.

🦠💡 Bacteria have millions of secret weapons against viruses! Researchers used AI to uncover millions of new bacterial proteins likely involved in antiviral defense — suggesting immunity genes make up ~1.5% of the genome, 3× more than thought. 🔗 www.pasteur.fr/en/research-... @audeber.bsky.social

Bacteria Have Millions of Secret Weapons Against Viruses

Millions of new proteins with predicted roles in defence against viruses have been identified in bacteria. It was thought that around 0.5% of the average bacterial genome had some involvement in immun...

pasteur.fr

T
T
T
T